Biotrue has named Jeff Stuckey as its CEO, the company said this week.
Stuckey previously was a business and organizational consultant to life sciences companies. He has also served on the board at Autoquant Imaging, and was CEO and executive vice president at Universal Imaging, now Molecular Devices.
Cyntellect this week said it has appointed three new members to its scientific advisory board: Alan Aderem, director of the Institute for Systems Biology and former head of the signal transduction laboratory at The Rockefeller University; Charles Cantor, chief scientific officer at Sequenom and former chair and professor of biomedical engineering at Boston University; and Michael Hanley, vice president of discovery research at Amylin Pharmaceuticals and former senior faculty at Imperial College in Cambridge, UK.
The Stanford University School of Medicine this week said that it has appointed Renee Reijo Pera as director of embryonic stem cell research and education for the Stanford Institute for Stem Cell Biology and Regenerative Medicine.
Reijo Pera joins Stanford from the University of California, San Francisco, where she was co-director of the human embryonic stem cell research center and director of a training program funded through the California Institute for Regenerative Medicine.